Nonprofit · EIN 95-4335088
LYMPHOMA RESEARCH FOUNDATION
Tax-exempt · NEW YORK, NY 10005
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $14,181,182 | $14,306,630 | -$125,448 | $42,720,239 | $8,187,980 | $34,532,259 |
| June 30, 2024 | 990 | $13,925,738 | $13,429,805 | $495,933 | $42,834,039 | $10,073,192 | $32,760,847 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $8,904,346
- Program service revenue
- $3,728,175
- Investment income
- $1,483,381
- Royalties
- $39,340
- Net gain from sales of assets
- $246,799
- Other revenue
- $65,280
Expenses
- Grants and similar amounts paid
- $2,855,823
- Compensation of officers, directors and key employees
- $1,122,845
- Other salaries and wages
- $3,392,283
- Salaries, compensation and benefits (total)
- $5,420,452
- Professional fundraising fees
- $0
- Legal fees
- $34,980
- Accounting fees
- $65,757
- Occupancy
- $434,793
- Travel
- $472,254
- Depreciation
- $13,128
- Program services (functional)
- $10,243,210
- Management and general (functional)
- $1,857,610
- Fundraising (functional)
- $2,205,810
Balance sheet and other
- Total assets, start of year
- $42,834,039
- Total assets, end of year
- $42,720,239
- Total liabilities, end of year
- $8,187,980
- Net assets, end of year
- $34,532,259
- Land, buildings and equipment
- $20,355
- Publicly traded securities
- $36,392,748
- Net assets without donor restrictions
- $11,704,462
- Net assets with donor restrictions
- $22,827,797
- Gross receipts
- $65,290,071
- Employees
- 47
- Volunteers
- 20,000
- Year formed
- 1991
- State of legal domicile
- CA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| MEGHAN GUTIERREZ | CHIEF EXECUTIVE OFFICER Officer | 45 | $364,424 | $18,342 |
| LAURA WALLENSTEIN | CHIEF PHILANTHROPY OFFICER Key employee | 35 | $235,033 | $45,347 |
| SARAH QUINLAN | CHIEF PROGRAM OFFICER Key employee | 35 | $213,956 | $22,864 |
| CHRISTA BOGGIO | CONTROLLER Highest-paid employee | 45 | $192,672 | $15,618 |
| NICHOLAS GUERCIO | SENIOR DIRECTOR, MARKETING & COMMUNICATION Highest-paid employee | 35 | $181,070 | $12,528 |
| VICTOR GONZALEZ | SENIOR DIRECTOR, PATIENT PROGRAMS Highest-paid employee | 35 | $170,659 | $20,699 |
| MICAH BANNER | SENIOR DIRECTOR, INDIVIDUAL GIVING Highest-paid employee | 35 | $171,546 | $9,478 |
| LYNNE WINTER | SENIOR PHILANTHROPIC ADVISOR Highest-paid employee | 28 | $153,446 | $14,531 |
| HILLEL HYMAN | CHIEF OPERATING OFFICER (EFF. 12/2024) Officer | 35 | $14,808 | $0 |
| JEFF BLOCK | VICE CHAIR AND TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| KIM METCALF | VICE CHAIR Trustee or director, Officer | 2 | $0 | $0 |
| LEIGH OLSEN | SECRETARY Trustee or director, Officer | 2 | $0 | $0 |
| STEVEN EICHBERG | BOARD CHAIR Trustee or director, Officer | 2 | $0 | $0 |
| ANN LACASCE MD MMSC | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| ELLEN WALKER | BOARD MEMBER (EFF. 2/2025) Trustee or director | 1 | $0 | $0 |
16 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| HARRIET GREENBERG | BOARD MEMBER Trustee or director | 1 | $0 |
| JOEL POLLICK | BOARD MEMBER Trustee or director | 1 | $0 |
| JOHN A NELSON | BOARD MEMBER Trustee or director | 1 | $0 |
| JOHN P LEONARD MD | BOARD MEMBER Trustee or director | 1 | $0 |
| KEVIN SHEA | BOARD MEMBER Trustee or director | 1 | $0 |
| KRISTI HENDRIKS | BOARD MEMBER (EFF. 7/2024) Trustee or director | 1 | $0 |
| LAURENCE DOBOSH | BOARD MEMBER Trustee or director | 1 | $0 |
| LINDSAY SPRINGER | BOARD MEMBER Trustee or director | 1 | $0 |
| MICHAEL FROY | BOARD MEMBER Trustee or director | 1 | $0 |
| MICHAEL WERNER | BOARD MEMBER Trustee or director | 1 | $0 |
| PATRICIA KANE | BOARD MEMBER (EFF. 6/2025) Trustee or director | 1 | $0 |
| PAUL MAJKOWSKI | BOARD MEMBER (EFF. 6/2025) Trustee or director | 1 | $0 |
| RAMESH SUBRAHMANIAN | BOARD MEMBER Trustee or director | 1 | $0 |
| ROBERT MCCAULEY | BOARD MEMBER Trustee or director | 1 | $0 |
| SCOTT PANSKY | BOARD MEMBER Trustee or director | 1 | $0 |
| WHITNEY NEIGHBORS | BOARD MEMBER (EFF. 2/2025) Trustee or director | 1 | $0 |
990 for the year ended June 30, 2024: 29 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| MEGHAN GUTIERREZ | CHIEF EXECUTIVE OFFICER Officer | 35 | $329,934 | $11,685 |
| LAURA WALLENSTEIN | CHIEF PHILANTHROPY OFFICER Key employee | 35 | $231,590 | $22,857 |
| CAROLINA FLORES THRU 52023 | SENIOR DIRECTOR OF FINANCE Former | 35 | $206,459 | $15,553 |
| SARAH QUINLAN | CHIEF PROGRAM OFFICER Key employee | 35 | $190,287 | $21,717 |
| VICTOR GONZALEZ | SENIOR DIRECTOR, PATIENT PRG. Highest-paid employee | 35 | $151,304 | $19,342 |
| MICAH BANNER | SENIOR DIRECTOR, IND. GIVING Highest-paid employee | 35 | $156,834 | $8,849 |
| NICHOLAS GUERCIO | SNR DIR. OF MARKETING & COMM Highest-paid employee | 35 | $145,500 | $11,286 |
| RACHEL ELMORE THRU 1112024 | ASSOC. DIR OR AUDIENCE ANAL Highest-paid employee | 35 | $103,187 | $16,686 |
| EVA MIGLIORE | ASSOC DIR OF SCI & PROF PROG Highest-paid employee | 35 | $113,046 | $5,772 |
| STEVEN EICHBERG | BOARD CHAIR Trustee or director, Officer | 2 | $0 | $0 |
| JEFF BLOCK | VICE CHAIR AND TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| KIM METCALF | VICE CHAIR Trustee or director, Officer | 2 | $0 | $0 |
| LEIGH OLSON | SECRETARY Trustee or director, Officer | 2 | $0 | $0 |
| MICHAEL FROY | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| HARRIET GREENBERG | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| ROBERT MCCAULEY | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| JOHN A NELSON | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| SCOTT PANSKY | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| DIANE PARKS | BOARD MEMBER (THRU 7/2023) Trustee or director | 1 | $0 | $0 |
| JOEL POLLICK | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| KEVIN SHEA | BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| JOHN P LEONARD MD | PAST CHAIR, SCIENTIFIC ADVISOR Trustee or director | 1 | $0 | $0 |
| STEVEN J PRINCE | PAST CHAIR, BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| MICHAEL WERNER | PAST CHAIR, BOARD MEMBER Trustee or director | 1 | $0 | $0 |
| ANN LACASCE MD MMSC | BOARD MEMBER (EFF. 7/2023) Trustee or director | 1 | $0 | $0 |
| LAURENCE DOBOSH | BOARD MEMBER (EFF. 3/2024) Trustee or director | 1 | $0 | $0 |
| LINDSAY SPRINGER | BOARD MEMBER (EFF. 9/2023) Trustee or director | 1 | $0 | $0 |
| RAMESH SUBRAHMANIAN | BOARD MEMBER (EFF. 7/2023) Trustee or director | 1 | $0 | $0 |
| Paul Belanger | CONTRACTED CFO (THRU 12/2023) Officer | 35 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- WALL ST PLAZA 88 PINE STREET 2400, NEW YORK, NY 10005-1801
- In care of
- % THE ORGANIZATION
- Principal officer (990 for 2024)
- MEGHAN GUTIERREZ, WALL ST PLAZA 88 PINE STREET 2400, NEW YORK, NY 10005
- Signed the 990
- MEGHAN GUTIERREZ, CEO
- Phone
- (212) 349-2910
- Return prepared by
- BDO USA
Mission
SEE SCHEDULE O
Program accomplishments
- EDUCATIONAL PROGRAMS AND SUPPORT SERVICES - THE LYMPHOMA RESEARCH FOUNDATION OFFERS A WIDE RANGE OF EDUCATIONAL PROGRAMS AND SUPPORT SERVICES FOR LYMPHOMA PATIENTS AND THEIR LOVED ONES, INCLUDING IN-PERSON AND VIRTUAL EDUCATION PROGRAMS AND EDUCATIONAL PUBLICATIONS. THE FOUNDATION HELPLINE PROVIDES LYMPHOMA PATIENTS AND THEIR LOVED ONES WITH INDIVIDUALIZED SUPPORT AND ANSWER ANY LYMPHOMA-RELATED QUESTIONS. THE FOUNDATION ALSO OFFERS A WIDE RANGE OF LYMPHOMA-FOCUSED EDUCATIONAL ACTIVITIES DESIGNED TO INCREASE THE KNOWLEDGE, SKILLS AND PERFORMANCE OF HEALTHCARE PROFESSIONALS AND TO MAXIMIZE THE QUALITY OF CARE FOR LYMPHOMA PATIENTS.Expenses $4,613,721 · grants $86,000 · revenue $3,728,175
- RESEARCH AND SCIENTIFIC PROGRAMS - THE LYMPHOMA RESEARCH FOUNDATION'S RESEARCH PROGRAM IS GUIDED BY ITS ELITE SCIENTIFIC ADVISORY BOARD, COMPRISED OF 45 EXPERT LYMPHOMA CLINICIANS AND SCIENTISTS FROM ACROSS NORTH AMERICA. THE FOUNDATION FUNDS RESEARCH INVESTIGATING EVERY LYMPHOMA SUBTYPE AND REMAINS COMMITTED TO SUPPORTING EARLY CAREER SCIENTISTS TO ENSURE THE BEST AND BRIGHTEST SCIENCE MINDS ARE DEDICATED TO RESEARCHING LYMPHOMA. IN ADDITION TO DIRECTLY FUNDING RESEARCH GRANTS, THE FOUNDATION FACILITATES COLLABORATION AND PARTNERSHIPS AMONG ACADEMIC SCIENTISTS, CLINICIANS, INDUSTRY, REGULATORY AGENCIES, AND PATIENTS. THROUGH ITS GLOBAL LYMPHOMA CONSORTIA AND SCIENTIFIC WORKSHOPS, THE FOUNDATION MOBILIZES THE RESEARCH COMMUNITY TO OVERCOME SYSTEMIC CHALLENGES AND SPEED THE PROGRESS OF THE DEVELOPMENT OF NEW TREATMENTS AND UNDERSTANDING OF THE VARIOUS SUBTYPES OF LYMPHOMA.Expenses $3,912,536 · grants $2,769,823
- COMMUNITY OUTREACH AND ADVOCACY - THE LYMPHOMA RESEARCH FOUNDATION'S FOCUS INCLUDES COMMUNITY-BASED, PATIENT-CENTERED EDUCATION AND OUTREACH; INCREASING REPRESENTATION IN LYMPHOMA RESEARCH AND CLINICAL CARE AND COALESCING THE LYMPHOMA COMMUNITY AROUND AWARENESS INITIATIVES FOR THIS RARE DISEASE. THE FOUNDATION IS COMMITTED TO ADVOCATING ON BEHALF OF THE ENTIRE LYMPHOMA COMMUNITY IN SUPPORT OF THIS MISSION, WORKING COLLABORATIVELY WITH POLICYMAKERS, MEDICAL COMMUNITY, PATIENT ADVOCATES AND OTHER STAKEHOLDERS TO ADVANCE EFFORTS THAT WILL IMPROVE THE LIVES OF PEOPLE WITH LYMPHOMA. THE FOUNDATION SUPPORTS MEASURES WHICH WILL INCREASE FEDERAL FUNDING FOR LYMPHOMA RESEARCH AND ENSURE PATIENT ACCESS TO HIGH QUALITY CANCER CARE AND IMPROVED ANTI-CANCER TREATMENTS. THE FOUNDATION ALSO SUPPORTS EDUCATION AND OUTREACH EFFORTS TO IDENTIFY AND REACH UNDERSERVED PATIENT POPULATIONS.Expenses $1,716,953
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 95-4335088
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1996
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G80)
- Assets (IRS master file)
- $42,720,239
- Income (IRS master file)
- $65,290,071
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | – | – | – | IRS |
| 990 | June 2024 | – | – | – | IRS |
| 990 | June 2023 | $16,566,956 | $13,955,595 | $41,061,805 | IRS |
| 990 | June 2022 | $14,709,927 | $12,900,895 | $35,546,178 | IRS |
| 990 | June 2021 | – | – | – | IRS |
| 990 | June 2020 | – | – | – | IRS |
| 990 | June 2018 | – | – | – | IRS |
990-N: the IRS publishes only the latest e-Postcard per organization; earlier years appear here as 990.tax collects the monthly files. 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS.
Questions about LYMPHOMA RESEARCH FOUNDATION
- What is the EIN of LYMPHOMA RESEARCH FOUNDATION?
- The employer identification number (EIN) of LYMPHOMA RESEARCH FOUNDATION is 95-4335088.
- Is LYMPHOMA RESEARCH FOUNDATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1996.
- Are donations to LYMPHOMA RESEARCH FOUNDATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does LYMPHOMA RESEARCH FOUNDATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of LYMPHOMA RESEARCH FOUNDATION due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did LYMPHOMA RESEARCH FOUNDATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of LYMPHOMA RESEARCH FOUNDATION?
- The 990 for the year ended June 30, 2025 names MEGHAN GUTIERREZ.
- Who are the officers and directors of LYMPHOMA RESEARCH FOUNDATION?
- The 990 for the year ended June 30, 2025 lists 31 people; 9 received compensation from the organization, the highest $364,424 (MEGHAN GUTIERREZ, CHIEF EXECUTIVE OFFICER).
- How much revenue does LYMPHOMA RESEARCH FOUNDATION have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $14,181,182, expenses of $14,306,630 and total assets of $42,720,239 at year end.
Other nonprofits in NEW YORK
- BREAKTHROUGH T1D EIN 23-1907729 · last filed 990 for 2025
- UNITED CEREBRAL PALSY ASSOCIATIONS OF NEW YORK STATE INC EIN 13-1623856 · last filed 990 for 2025
- UNITED CEREBRAL PALSY OF NEW YORK CITY INC EIN 13-5654532 · last filed 990 for 2025
- NATIONAL MULTIPLE SCLEROSIS SOCIETY EIN 13-5661935 · last filed 990 for 2025
- FUND FOR PUBLIC HEALTH IN NEW YORK INC EIN 05-0539199 · last filed 990 for 2025
- CROHNS & COLITIS FOUNDATION INC EIN 13-6193105 · last filed 990 for 2024
- NATIONAL KIDNEY FOUNDATION INC EIN 13-1673104 · last filed 990 for 2025
- THE MARK FOUNDATION FOR CANCER RESEARCH US LTD EIN 36-4825921 · last filed 990 for 2024
All nonprofits in NEW YORK · New York · Voluntary health associations and medical disciplines